Compound Detail
CHEMBL4095072
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4095072 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SHJYUDRICHEQHX-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
3
PK Parameters
20
Publications
0
Known Names
Molecular Properties
429.5
MW (Da)
3.57
ALogP
5
HBA
3
HBD
92.9
PSA (Ų)
0.46
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 6.64 | 6.64 | 230.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2550.0 | ng.hr.mL-1 | Mus musculus |
| Cmax | 2141.88 | nM | Mus musculus |
| Tmax | 3.25 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 230.0 | nM | 6.64 | Inhibition of human recombinant BMP6-stimulated hepcidin mRNA expression in huma... | 28705644 |
| HepG2 | IC50 | = | 230.0 | nM | 6.64 | Inhibition of human recombinant BMP6-stimulated hepcidin mRNA expression in huma... | 29079471 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29079471 | 10.1016/j.bmcl.2017.10.031 | Tyrosine-protein kinase ABL1 | 7 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Tyrosine-protein kinase ABL1 | 7 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Unchecked | 4 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Mus musculus | 4 |
| 29079471 | 10.1016/j.bmcl.2017.10.031 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 29079471 | 10.1016/j.bmcl.2017.10.031 | Platelet-derived growth factor receptor alpha | 3 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Epidermal growth factor receptor | 3 |
| 29079471 | 10.1016/j.bmcl.2017.10.031 | Epidermal growth factor receptor | 3 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Platelet-derived growth factor receptor alpha | 3 |
| 29079471 | 10.1016/j.bmcl.2017.10.031 | Fibroblast growth factor receptor 3 | 3 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Fibroblast growth factor receptor 3 | 3 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Fibroblast growth factor receptor 4 | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | cGMP-dependent protein kinase 1 | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Receptor-type tyrosine-protein kinase FLT3 | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Mast/stem cell growth factor receptor Kit | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Fibroblast growth factor receptor 2 | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Mitogen-activated protein kinase 14 | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | cAMP-dependent protein kinase catalytic subunit beta | 2 |
| 28705644 | 10.1016/j.bmcl.2017.07.004 | Tyrosine-protein kinase Lyn | 2 |
Data from ChEMBL 36 via Core Engine